Drug Profile


Alternative Names: capsavanil; DA 5018; KR 25018

Latest Information Update: 08 Nov 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Korea Research Institute of Chemical Technology
  • Developer Dong-A Pharmaceutical
  • Class Non-opioid analgesics
  • Mechanism of Action TRPV cation channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Diabetic neuropathies; Neuralgia; Pain; Pruritus

Most Recent Events

  • 30 Jan 2001 Phase-II clinical trials for Pain in South Korea (Unknown route)
  • 23 Mar 2000 Preclinical development for Pruritus in South Korea (Unknown route)
  • 23 Mar 2000 A study has been added to the Skin disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top